Jefferies analyst, Brian Abrahams, reiterated his Buy rating on Celgene (NASDAQ: CELG) despite its partner, JUNO (NASDAQ: JUNO), announcing its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE